![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of RAB5B mRNA | CTD | PMID:22206623 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Rab5b (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Rab5b (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RAB5B mRNA | CTD | PMID:21215274 and PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Rab5b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RAB5B mRNA | CTD | PMID:21570461 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of RAB5B mRNA | CTD | PMID:20188158 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of RAB5B mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RAB5B mRNA | CTD | PMID:28628672 | 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of RAB5B mRNA | CTD | PMID:19162173 | 4,4'-diaminodiphenylmethane | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of RAB5B mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of RAB5B mRNA | CTD | PMID:28628672 | acrylamide | decreases expression | ISO | Rab5b (Mus musculus) | 6480464 | Acrylamide results in decreased expression of RAB5B mRNA | CTD | PMID:30807115 | benzo[a]pyrene | decreases expression | ISO | Rab5b (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of RAB5B mRNA | CTD | PMID:22228805 | benzo[e]pyrene | decreases methylation | ISO | RAB5B (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of RAB5B intron | CTD | PMID:30157460 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RAB5B mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | RAB5B (Homo sapiens) | 6480464 | bisphenol A results in increased expression of RAB5B protein | CTD | PMID:34186270 | bisphenol A | decreases expression | ISO | Rab5b (Mus musculus) | 6480464 | bisphenol A results in decreased expression of RAB5B mRNA | CTD | PMID:33221593 | bisphenol F | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RAB5B mRNA | CTD | PMID:28628672 | cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of RAB5B promoter | CTD | PMID:22457795 | cadmium dichloride | increases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of RAB5B protein | CTD | PMID:24527689 | carbon nanotube | decreases expression | ISO | Rab5b (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of RAB5B mRNA | CTD | PMID:25554681 | chlordecone | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | Chlordecone results in increased expression of RAB5B mRNA | CTD | PMID:33711761 | choline | multiple interactions | ISO | Rab5b (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RAB5B mRNA | CTD | PMID:20938992 | cisplatin | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of RAB5B mRNA | CTD | PMID:27594783 | cisplatin | increases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Cisplatin results in increased expression of RAB5B mRNA | CTD | PMID:27392435 | cytarabine | increases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Cytarabine results in increased expression of RAB5B mRNA | CTD | PMID:19194470 | dexamethasone | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of RAB5B mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RAB5B mRNA | CTD | PMID:28628672 | diquat | decreases expression | ISO | Rab5b (Mus musculus) | 6480464 | Diquat results in decreased expression of RAB5B protein | CTD | PMID:36851058 | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of RAB5B mRNA | CTD | PMID:21551480 | fluvastatin | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [zoledronic acid co-treated with fluvastatin] results in increased expression of RAB5B mRNA | CTD | PMID:16996129 | folic acid | multiple interactions | ISO | Rab5b (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RAB5B mRNA | CTD | PMID:20938992 | glyphosate | increases expression | ISO | RAB5B (Homo sapiens) | 6480464 | glyphosate results in increased expression of RAB5B mRNA | CTD | PMID:31295307 | hexane | decreases methylation | EXP | | 6480464 | n-hexane results in decreased methylation of RAB5B promoter | CTD | PMID:23740543 | indometacin | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of RAB5B mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RAB5B mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of RAB5B protein | CTD | PMID:32959892 | L-methionine | multiple interactions | ISO | Rab5b (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RAB5B mRNA | CTD | PMID:20938992 | leflunomide | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | leflunomide results in decreased expression of RAB5B mRNA | CTD | PMID:28988120 | methapyrilene | decreases methylation | ISO | RAB5B (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of RAB5B intron | CTD | PMID:30157460 | N-methyl-4-phenylpyridinium | affects expression | ISO | RAB5B (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium affects the expression of RAB5B mRNA | CTD | PMID:12710931 | nickel dichloride | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | nickel chloride results in decreased expression of RAB5B mRNA | CTD | PMID:17312168 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RAB5B mRNA | CTD | PMID:33387578 | PCB138 | multiple interactions | ISO | Rab5b (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of RAB5B mRNA | CTD | PMID:19162173 | pirinixic acid | decreases expression | ISO | Rab5b (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of RAB5B mRNA | CTD | PMID:20813756 | potassium dichromate | increases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Potassium Dichromate results in increased expression of RAB5B protein | CTD | PMID:23718831 | resveratrol | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | resveratrol results in increased expression of RAB5B protein | CTD | PMID:25505154 | resveratrol | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of RAB5B mRNA | CTD | PMID:23557933 | silver atom | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Silver results in decreased expression of RAB5B mRNA | CTD | PMID:26551752 | silver(0) | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Silver results in decreased expression of RAB5B mRNA | CTD | PMID:26551752 | sodium arsenate | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | sodium arsenate results in increased expression of RAB5B mRNA | CTD | PMID:21795629 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of RAB5B mRNA | CTD | PMID:31150632 | titanium dioxide | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | titanium dioxide results in increased expression of RAB5B mRNA | CTD | PMID:29264374 | valproic acid | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of RAB5B mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | RAB5B (Homo sapiens) | 6480464 | Valproic Acid affects the expression of RAB5B mRNA | CTD | PMID:25979313 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of RAB5B mRNA | CTD | PMID:19015723 | zoledronic acid | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [zoledronic acid co-treated with fluvastatin] results in increased expression of RAB5B mRNA | CTD | PMID:16996129 | |